Gain Therapeutics
GANX
GANX
33 hedge funds and large institutions have $8.24M invested in Gain Therapeutics in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
7% more capital invested
Capital invested by funds: $7.68M → $8.24M (+$560K)
2.64% more ownership
Funds ownership: 7.48% → 10.11% (+2.6%)
Holders
33
Holding in Top 10
–
Calls
$47K
Puts
$17K
Top Buyers
| 1 | +$623K | |
| 2 | +$240K | |
| 3 | +$199K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$149K |
| 5 |
Kovitz Investment Group Partners
Chicago,
Illinois
|
+$90.9K |
Top Sellers
| 1 | -$86K | |
| 2 | -$38K | |
| 3 | -$4.32K | |
| 4 |
BlackRock
New York
|
-$3.16K |